Abstract
Purpose
To explore the associations between lifestyle-related factors and tumor-related prognostic factors in women treated for primary breast cancer, and to detect possible differences between the associations in pre- and postmenopausal women.
Methods
Associations between tumor-related prognostic factors, including the composite endpoint risk of recurrence (RoR), body mass index (BMI), comorbidity (Charlson comorbidity index), basic physical functioning (SF-36), physical activity, smoking, and alcohol consumption were examined with binary logistic regression analysis in a national cohort of 4917 women treated for primary breast cancer. In addition, statistical interactions between predictors and menopausal status were assessed in order to determine if their strength differed significantly as a function of menopausal status.
Results
Higher BMI, reduced physical function, reduced physical activity, and greater alcohol consumption were all statistically significantly associated with two or more tumor-related factors indicating a poorer prognosis. Interaction analysis revealed that BMI was significantly stronger associated with RoR among premenopausal women than among postmenopausal women (interaction ip = 0.048). Similarly, a significant association between RoR and physical function was only seen in the premenopausal population (ip = 0.008). This pattern was also seen between RoR and daily alcohol consumption, which only reached statistical significance in the total population and in premenopausal women (ip < 0.001).
Conclusion
Premenopausal women who are overweight and have poorer physical function have poorer prognosis at the time of diagnosis, suggesting the possible relevance of stratifying adjuvant treatment according to guidelines, BMI, and menopausal status.
Similar content being viewed by others
References
Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, Rosso S, Coebergh JW, Comber H, Forman D, Bray F (2013) Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer 49:1374–1403. doi:10.1016/j.ejca.2012.12.027
Christiansen P, Al-Suliman N, Bjerre K, Moller S, Danish Breast Cancer Cooperative Group (2008) Recurrence pattern and prognosis in low-risk breast cancer patients–data from the DBCG 89-A programme. Acta Oncol 47:691–703. doi:10.1080/02841860802056594
Hauner D, Janni W, Rack B, Hauner H (2011) The effect of overweight and nutrition on prognosis in breast cancer. Dtsch Arztebl Int 108:795–801. doi:10.3238/arztebl.2011.0795
Patterson RE, Cadmus LA, Emond JA, Pierce JP (2010) Physical activity, diet, adiposity and female breast cancer prognosis: a review of the epidemiologic literature. Maturitas 66:5–15. doi:10.1016/j.maturitas.2010.01.004
Harlan LC, Klabunde CN, Ambs AH, Gibson T, Bernstein L, McTiernan A, Meeske K, Baumgartner KB, Ballard-Barbash R (2009) Comorbidities, therapy, and newly diagnosed conditions for women with early stage breast cancer. J Cancer Surviv 3:89–98. doi:10.1007/s11764-009-0084-3
Berglund A, Wigertz A, Adolfsson J, Ahlgren J, Fornander T, Warnberg F, Lambe M (2012) Impact of comorbidity on management and mortality in women diagnosed with breast cancer. Breast Cancer Res Treat 135:281–289. doi:10.1007/s10549-012-2176-4
Anders CK, Johnson R, Litton J, Phillips M, Bleyer A (2009) Breast cancer before age 40 years. Semin Oncol 36:237–249. doi:10.1053/j.seminoncol.2009.03.001
Beadle BM, Woodward WA, Buchholz TA (2011) The impact of age on outcome in early-stage breast cancer. Semin Radiat Oncol 21:26–34. doi:10.1016/j.semradonc.2010.09.001
Pritchard KI (2007) Adjuvant therapy of the very young woman. Breast 16(Suppl 2):S136–S146
Christensen S, Zachariae R, Jensen AB, Vaeth M, Moller S, Ravnsbaek J, von der Maase H (2009) Prevalence and risk of depressive symptoms 3–4 months post-surgery in a nationwide cohort study of Danish women treated for early stage breast-cancer. Breast Cancer Res Treat 113:339–355. doi:10.1007/s10549-008-9920-9
McHorney CA, Haley SM, Ware JE Jr (1997) Evaluation of the MOS SF-36 Physical Functioning Scale (PF-10): II. Comparison of relative precision using Likert and Rasch scoring methods. J Clin Epidemiol 50:451–461
Washburn RA, Smith KW, Jette AM, Janney CA (1993) The physical activity scale for the elderly (PASE): development and evaluation. J Clin Epidemiol 46:153–162
Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40:373–383
Rose DP, Vona-Davis L (2010) Interaction between menopausal status and obesity in affecting breast cancer risk. Maturitas 66:33–38. doi:10.1016/j.maturitas.2010.01.019
Vona-Davis L, Howard-McNatt M, Rose DP (2007) Adiposity, type 2 diabetes and the metabolic syndrome in breast cancer. Obes Rev 8:395–408
Destounis S, Newell M, Pinsky R (2011) Breast imaging and intervention in the overweight and obese patient. AJR Am J Roentgenol 196:296–302. doi:10.2214/AJR.10.5556
Kerlikowske K, Walker R, Miglioretti DL, Desai A, Ballard-Barbash R, Buist DS (2008) Obesity, mammography use and accuracy, and advanced breast cancer risk. J Natl Cancer Inst 100:1724–1733. doi:10.1093/jnci/djn388
Hunt KA, Sickles EA (2000) Effect of obesity on screening mammography: outcomes analysis of 88,346 consecutive examinations. AJR Am J Roentgenol 174:1251–1255. doi:10.2214/ajr.174.5.1741251
Friedenreich CM (2010) The role of physical activity in breast cancer etiology. Semin Oncol 37:297–302. doi:10.1053/j.seminoncol.2010.05.008
Mittendorf R, Longnecker MP, Newcomb PA, Dietz AT, Greenberg ER, Bogdan GF, Clapp RW, Willett WC (1995) Strenuous physical activity in young adulthood and risk of breast cancer (United States). Cancer Causes Control 6:347–353
Hardman AE (2001) Physical activity and cancer risk. Proc Nutr Soc 60:107–113
Chlebowski RT (2013) Nutrition and physical activity influence on breast cancer incidence and outcome. Breast 22(Suppl 2):S30–S37. doi:10.1016/j.breast.2013.07.006
Seitz HK, Pelucchi C, Bagnardi V, La Vecchia C (2012) Epidemiology and pathophysiology of alcohol and breast cancer: update 2012. Alcohol Alcohol 47:204–212. doi:10.1093/alcalc/ags011
Silvera SA, Jain M, Howe GR, Miller AB, Rohan TE (2006) Energy balance and breast cancer risk: a prospective cohort study. Breast Cancer Res Treat 97:97–106. doi:10.1007/s10549-005-9098-3
Emaus A, Veierod MB, Tretli S, Finstad SE, Selmer R, Furberg AS, Bernstein L, Schlichting E, Thune I (2010) Metabolic profile, physical activity, and mortality in breast cancer patients. Breast Cancer Res Treat 121:651–660. doi:10.1007/s10549-009-0603-y
Griggs JJ, Mangu PB, Anderson H, Balaban EP, Dignam JJ, Hryniuk WM, Morrison VA, Pini TM, Runowicz CD, Rosner GL, Shayne M, Sparreboom A, Sucheston LE, Lyman GH, American Society of Clinical Oncology (2012) Appropriate chemotherapy dosing for obese adult patients with cancer: American Society of Clinical Oncology clinical practice guideline. J Clin Oncol 30:1553–1561. doi:10.1200/JCO.2011.39.9436
Carroll J, Protani M, Walpole E, Martin JH (2012) Effect of obesity on toxicity in women treated with adjuvant chemotherapy for early-stage breast cancer: a systematic review. Breast Cancer Res Treat 136:323–330. doi:10.1007/s10549-012-2213-3
Jenkins P, Elyan S, Freeman S (2007) Obesity is not associated with increased myelosuppression in patients receiving chemotherapy for breast cancer. Eur J Cancer 43:544–548
Kroman N, Jensen MB, Wohlfahrt J, Mouridsen HT, Andersen PK, Melbye M (2000) Factors influencing the effect of age on prognosis in breast cancer: population based study. BMJ 320:474–478
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interests
The authors have no conflicts of interests to disclose.
Informed consent
Informed consent was obtained from all individual participants included in the study.
Rights and permissions
About this article
Cite this article
Guldberg, T.L., Christensen, S., Zachariae, R. et al. Prognostic factors in early breast cancer associated with body mass index, physical functioning, physical activity, and comorbidity: data from a nationwide Danish cohort. Breast Cancer Res Treat 162, 159–167 (2017). https://doi.org/10.1007/s10549-016-4099-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10549-016-4099-y